Diaceutics and PCC launch NGS Concordance Study to advance precision oncology and support informed biomarker testing
This collaborative industry initiative will assess concordance in variant detection across next-generation sequencing (NGS) panels and platforms used in routine clinical practice
PCC presents NEW infographic highlighting its impact and vision for precision oncology
The Pathway to Precision Cancer Care: A Strategic and Operational Guide to Enhance Patient Access to CGP
Galicia leads the way in implementing comprehensive genomic profiling as a systemic tool for precision oncology
An agreement signed between SERGAS, and the Precision Cancer Consortium seeks to accelerate the implementation of CGP for all patients with solid tumors from initial diagnosis.
2025, Year in Review
“Our vision is to make precision oncology and CGP the new normal – only together can we achieve this.” A message from Precision Cancer Consortium Chair
PCC launches global guide to expand access to CGP and precision cancer care
The Pathway to Precision Cancer Care: A Strategic and Operational Guide to Enhance Patient Access to CGP
Insights from Professor Paul Hofman on shaping the future of precision medicine with liquid biopsy
Professor Hofman discussed how liquid biopsy has become an essential component of molecular testing in aNSCLC.
Lean Six Sigma Workflow Optimization Modular Training Available for FREE DOWNLOAD – NEW
Lean Six Sigma is an approach to laboratory workflow optimization to improve diagnostic testing turnaround time and quality.
Precision Cancer Consortium strengthens its membership with the addition of industry powerhouse
PCC has bolstered its membership with the addition of Bristol Myers Squibb (BMS).
Expert Insights on Pathology in Clinical Trials
These 10-minute expert-led videos highlight the vital role of pathologists in the success of clinical studies.
PCC at ASCO 2025
A Scientific Steering Committee, featuring leading oncologist and pathologist key opinion leaders, was held on Friday, May 30, 2025